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Abstract
Background: Individuals with low cardiovascular risk factor profiles experience lower rates of cardiovascular diseases, but associations with 
geriatric syndromes are unclear. We tested whether individuals with low cardiovascular disease risk, aged 60–69 years old at baseline in two 
large cohorts, were less likely to develop aging-related adverse health outcomes.
Methods: Data were from population representative medical records (Clinical Practice Research Datalink [CPRD] England, n = 239,591) and 
healthy volunteers (UK Biobank [UKB], n = 181,820), followed for ≤10 years. A cardiovascular disease risk score (CRS) summarized smoking 
status, LDL-cholesterol, blood pressure, body mass index, fasting glucose and physical activity, grouping individuals as low (ie, all factors near 
ideal), moderate, or high CRS. Logistic regression, Cox models, and Fine and Grey risk models tested the associations between the CRS and 
health outcomes.
Results: Low CRS individuals had less chronic pain (UKB: baseline odds ratio = 0.52, confidence interval [CI] = 0.50–0.54), lower incidence of 
incontinence (CPRD: subhazard ratio [sub-HR] = 0.75, 0.63–0.91), falls (sub-HR = 0.82, CI = 0.73–0.91), fragility fractures (sub-HR = 0.78, 
CI = 0.65–0.93), and dementia (vs. high risks; UKB: sub-HR = 0.67, CI = 0.50–0.89; CPRD: sub-HR = 0.79, CI = 0.56–1.12). Only 5.4% in 
CPRD with low CRS became frail (Rockwood index) versus 24.2% with high CRS. All-cause mortality was markedly lower in the low CRS 
group (vs. high CRS; HR = 0.40, 95% CI = 0.35–0.47). All associations showed dose–response relationships, and results were similar in both 
cohorts.
Conclusions: Persons aged 60–69  years with near-ideal cardiovascular risk factor profiles have substantially lower incidence of geriatric 
conditions and frailty. Optimizing cardiovascular disease risk factors may substantially reduce the burden of morbidity in later life.
Keywords: Cardiovascular risk, Healthy aging, Frailty, Incontinence, Chronic pain
Evidence on the combined effects of cardiovascular disease (CVD) 
risk factors on common conditions of older age is unclear, with few 
studies showing an association between cardiovascular risk and 
loss of functional status. A  recent follow-up of the Chicago Heart 
Association study including 25,804 participants found that favorable 
cardiovascular risks in early middle age reduced overall morbidity (1). 
A smaller study (n = 5,248) in adults aged 65 years and older found 
that lifestyle factors including not smoking, higher physical activity, 
better quality diet, and not being obese were associated with a com-
pression in years of disability later in life (2), in line with previous 
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findings from the Framingham Disability Study (3). The ARIC and 
Northern Manhattan studies identified an association between cardio-
vascular risk factors and the ability to maintain long-term functional 
status (4,5), and an analysis of the Seven Countries Study found a pos-
sible association with incident dementia (6). However, data on specific 
age-related outcomes, such as frailty, falls, and incontinence, and the 
geriatric conditions that may mediate these associations have to our 
knowledge not been reported (1–6).
The recent availability of detailed clinical and functional data col-
lected in large cohorts offers the opportunity to selectively study the 
relatively few older individuals who are free of cardiovascular risk 
factors. Here, we used data from two large cohorts: (a) the Clinical 
Practice Research Datalink (CPRD; n = 239,591) electronic medical 
records for complete primary care older populations in England and 
(b) the United Kingdom’s Biobank (“UKB”; n = 181,820) cohort of 
healthy volunteers. We tested the hypothesis that individuals aged 
60–69 years at baseline who had low cardiovascular risk profiles are 
less likely to develop geriatric clinical syndromes and frailty over the 
subsequent 10 years. We scored risk factor status for smoking, blood 
pressure, blood glucose, cholesterol, body mass index, and physical 
activity (with proxy markers where full data were not available). 
Individuals were classified into low (all factors near ideal), inter-
mediate, and high CVD risk groups. We focused on common clinical 
geriatric outcomes that could be ascertained in the available data, 
predominantly from primary care and linked hospital electronic 
medical records diagnoses plus baseline self-reports. This is the first 
study to estimate geriatric outcomes in large cohorts of people with 
near-perfect or low cardiovascular risk.
Methods
Data Sources: Clinical Practice Research Datalink
The Clinical Practice Research Datalink (CPRD) includes electronic 
medical records for primary care patients living in the community, 
nursing or residential settings from 674 UK primary care practices 
(7,8). Records include cardiovascular risk factor status, plus clini-
cal symptoms, diagnoses, and prescriptions recorded during routine 
clinical practice. As virtually the whole older population is regis-
tered with primary care, CPRD is considered representative of older 
adults in England (7). For this study, we used CPRD data linked to 
National Health Service Hospital Episode Statistics (HES) admission 
data and the UK government’s Office for National Statistics (ONS) 
death certificate.
We included adults aged 60–69 years and registered with a prac-
tice from 1 January 2000 onward. Individuals were followed for up 
to 10 years. Collection of CVD risk data by primary care practices 
was reimbursed, and based on the CVD risk classification rules, the 
data were adapted from the American Heart Association (9) (see 
Table  1 and Supplementary Methods): There were 239,591 indi-
viduals with risk data. Systolic blood pressure and body mass index 
were collected as part of a CVD risk factor reimbursement scheme 
or as part of clinical consultations. Total cholesterol and serum fast-
ing glucose assays were obtained by primary care as part of clini-
cal examinations. These data were included in a cardiovascular risk 
score (CRS) from records covering the time period when individuals 
were registered with practices with data declared up-to-standard by 
CPRD (7,10).
CPRD has Multiple Research Ethics Committee approval (05/
MRE04/87), with external data linkages including HES and ONS 
mortality data. CPRD is also covered by NIGB-ECC approval ECC 
5-05 (a) 2012. This analysis was approved by the Independent 
Scientific Advisory Committee for MHRA database research (ISAC) 
under protocol number 14_135RA.
Data Sources: UK Biobank
The UKB recruited 181,820 volunteers, aged 60–69 at baseline, through 
22 assessment centers across England, Wales, and Scotland. The sample 
is healthier and has lower risk factor rates than the general population 
(11). At baseline (2006–2010), participants completed questionnaires 
(including self-reported demographic, lifestyle, and disease status) 
and underwent physiological measurements (12). Participants gave 
informed consent for data linkage to national hospital inpatient admis-
sions, cancer registrations, and death registrations.
Ethical approval for UKB study was obtained from the North 
West Multi-Centre Research Ethics Committee.
From UKB, we included participants who had available informa-
tion to calculate the CRS under our criteria. Individuals were fol-
lowed from baseline interview (2006–2010) to hospital inpatient 
disease diagnosis (March 2016), cancer registration (September 
2015), or death (February 2016), with a maximum follow-up of 
9.2  years. Information on incident conditions were from hospital 
admissions recorded in the HES for England, the Patient Episode 
Database for Wales (PEDW), and the Scottish Morbidity Record 
(SMR) (12). Information on incident cancer events were obtained 
from the NHS Information Centre (NHS IC) for England and Wales, 
National Records of Scotland, and NHS Central Register. ONS 
death certificates were also used for incidence disease adjudication.
Cardiovascular Risk Score “CRS”
We developed a risk score based on information on cardiovascular risk 
factors, applying scoring criteria adapted from the American Heart 
Association (9). Definitions of the individual risk factors are set out 
below and summarized in Table 1 (and Supplementary Material) for 
CPRD and UKB. Each individual factor was scored 0 (high), 1 (inter-
mediate), and 2 (low) and summed into a total CRS score, without 
weighting. Study participant CRS were categorized as high (score 0–5), 
intermediate (6–9), and low CVD risk (10–12), to ensure a minimum 
of 5,000 study participants within each category in each cohort. Not 
all CPRD participants had measures of cholesterol and glucose levels. 
In UKB, blood measure data are not yet available, where necessary we 
used relevant diagnoses or treatments as proxies. In UKB, complete 
case analysis was used. In CPRD, where no data on a particular risk 
factor were available for an individual, they were classified as absent 
(item score = 2, “low”). Missing data in clinical records are unlikely 
to be missing at random (but likely reflects no clinical signs and low 
clinical suspicion), we made this cautious assumption of the risk being 
absent, rather than multiply imputing missing values.
Outcomes
Main outcomes considered in this study were geriatric syndromes 
commonly diagnosed in older persons, which could be adequately 
ascertained from the available data and hence differ between the 
two data sources used. We also report data on additional outcomes 
including all-cause mortality, coronary heart disease, stroke, and 
cancer to confirm associations seen previously and hence show our 
measure of the CRS is valid.
Assessment of baseline outcomes (UK Biobank)
UKB allowed estimation of self-reported health status, chronic pain, 
and frailty and measured lung function. Participants reported their 
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health as excellent, good, fair, or poor. Reported pain anywhere 
in the body (back; facial; headaches; hip; knee; neck/shoulder; 
stomach/abdominal) was considered as chronic pain if it lasted for 
more than 3  months. Grip strength was measured in both hands 
using a hydraulic hand dynamometer and the maximum reading 
was categorized into sex-specific quintiles. The prevalence of frailty 
was estimated using a modified Fried Frailty phenotype (13) and 
included two or more of self-reported weight loss, self-reported ex-
haustion, self-reported slow walking pace, or low measured grip 
strength (lowest quintile, sex specific). The low physical activity cri-
teria were excluded from our definition as this is also a component 
of the CRS. A previous study showed that a four-criteria definition 
of Fried Frailty, excluding physical activity, had good specificity 
(0.98) but lower sensitivity (0.62) (14). Lung function was assessed 
by Vitalograph Pneumotrac 6800 spirometer and forced expiratory 
volume in 1 second (categorized into sex-specific quintiles).
Assessment of incident outcomes (UK Biobank and CPRD)
Incident events available in both data sets included all-cause mortal-
ity, incident CVD events (coronary heart disease, stroke, and heart 
failure), dementia, depression, chronic anemia, cancer, asthma, and 
chronic obstructive pulmonary disease. In CPRD, additional incident 
aging outcomes were available including osteoarthritis, loss of skin 
integrity (pressure sores/ulcers), urinary incontinence, falls, and hos-
pitalization due to fragility fracture (hip, vertebrae, humerus, distal 
radius, pelvis or pubic ramus, and ankle). Individuals with baseline 
diagnoses for each condition were excluded from analyses, to focus 
on incidence of the same conditions. In CPRD, analysis of more 
acute conditions (falls, fragility fractures, urinary incontinence, and 
pressure sores/ulcers) excluded those with relevant diagnostic codes 
recorded during 5 years prior to baseline (and 15 years prior to base-
line for osteoarthritis, as the quality of early recording the in the 
database is unclear).
Incident frailty in CPRD was classified using the Rockwood 
frailty index, implemented in electronic medical records. This cumu-
lative model includes 36 specified symptoms, signs, diseases, dis-
abilities, and abnormal laboratory values, collectively referred to as 
deficits (15,16). The index is scored fit (0 to <0.12), mildly frail (0.12 
to <0.24), moderately frail (0.24 to < 0.36), and severely frail (0.36 
to 1) (16). Frailty index scores were calculated at baseline and every 
subsequent year of follow-up.
Covariates
Socioeconomic factors were included as covariates in both CPRD 
and UKB. The two datasets use different systems of categorizing dep-
rivation, provided at source for data protection. UKB also included 
ethnicity, but ethnicity data in CPRD are incomplete.
Clinical Practice Research Datalink
Baseline sociodemographic variables in statistical models included 
age at the beginning of follow-up, sex, and quintiles of the 2007 
Index of Multiple Deprivation (IMD) for England (based on patient 
postcodes mapped to LSOA boundaries) (17).
UK Biobank
Reported ethnicity was categorized as White, Asian, Black, Chinese, 
Mixed, and other. Highest educational achievement was catego-
rized as 0 = none, 1 = CSEs (Certificate of Secondary Education), 
2  =  GCSEs/O-levels (General Certificate of Secondary Education 
to age 16), 3 = A-levels/NVQ/HND/HNC (further education after Ta
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age 16), 4  =  professional qualification, and 5  =  college/university 
degree. The Townsend (socioeconomic) deprivation index (18) 
is a composite measure from the participant’s postcode based on 
area employment, car ownership, home ownership, and household 
overcrowding.
Statistical Analysis
Baseline sociodemographic factors across CRS categories were 
compared using means and proportions. We used Cox propor-
tional hazards regression models to estimate hazard ratios (HRs) 
between CRS categories and all-cause mortality. For incident dis-
ease, we used Fine and Gray competing risk models to estimate 
HRs, including all-cause mortality as a competing risk: sub-HR 
(19). Logistic regression was used to assess cross-sectional asso-
ciations in UKB. High CRS was used as the reference group in all 
analyses. Analyses were adjusted for: baseline age, sex, socioeco-
nomic status (IMD for CPRD; education and Townsend depriv-
ation index for UK Biobank), ethnicity (UK Biobank only) and 
year of admission into the study (CPRD only). Sex, education and 
ethnicity were fitted as categorical variables. All analyses were car-
ried out using Stata v14.1.
Results
CPRD analyses included 239,591 primary care patients (mean age 
63.2 years [SD 2.8]), and UKB analyses included 181,820 volunteers 
(mean age 64.0 years [SD 2.8]; Table 2). Only 2.4% (n = 5,724) of 
the population representative CPRD had low CRS, compared with 
26.0% (n = 47,293) of UKB healthier volunteers, with 35.4% and 
6.5% having high CRS, respectively. Those with low CRS were less 
socioeconomically deprived and in UKB also had more educational 
qualifications. Mean follow-up was 5.9 years in CPRD (maximum 
10 years) and 6.7 years in UKB (maximum 9.2 years).
Baseline Outcomes (UK Biobank)
A modified Fried definition (13) of frailty was much less com-
mon with low CRS (odds ratio [OR]  =  0.24, confidence interval 
[CI] = 0.22–0.25) and intermediate CRS (OR = 0.41, CI = 0.39–0.44) 
Table 2. Baseline Characteristics by Cardiovascular Risk Score of Adults Aged 60–69 Years From CPRD and UK Biobank
High CV Risk (0–5) Intermediate CV Risk (6–9) Low CV Risk (10–12) Total p Trend
CPRD
 N 85,042 148,825 5,724 239,591
 % 35.4 62.2 2.4 100.0
 Age (SD) 63.1 (2.8) 63.3 (2.7) 62.8 (2.5) 63.2 (2.8) <.001
 Sex (% female) 49.6 51.6 57.0 51.0 <.001
 IMD (% most deprived quintile) 36.5 26.9 17.6 30.1 <.001
 Follow-up time (y) 6.0 5.9 4.9 5.9 <.001
UK Biobank
 N 11,847 122,680 47,293 181,820
 % 6.5 67.5 26.0 100.0
 Age (SD) 64.3 (2.8) 64.1 (2.8) 63.8 (2.8) 64.0 <.001
 Sex (% female) 38.3 48.4 62.4 51.4 <.001
 Ethnicity (% white) 96.6 97.1 98.0 97.3 <.001
 Townsend (% most deprived quintile) 29.2 19.3 15.2 18.9 <.001
 Education (% no qualification) 34.6 25.9 18.7 24.6 <.001
 Follow-up time (y) 6.5 6.7 6.8 6.7 <.001
Note: CPRD = Clinical Practice Research Datalink; CV = cardiovascular; IMD = 2007 Index of Multiple Deprivation for England (based on patient postcodes 
mapped to LSOA boundaries); Townsend = Townsend deprivation index.
Table 3. Odds Ratios (95% Confidence Intervals) for Baseline Aging Phenotypes by Cardiovascular Risk Score in Adults Aged 60–69 Years 
From UK Biobank (n = 181,820 Volunteers)
High CV 
Risk (0–5)
Intermediate CV  
Risk (6–9)
Low CV  
Risk (10–12)
Cases Ref. Cases OR 95% CI p Value Cases OR 95% CI p Value
Aging phenotypes
 Frailty (modified Fried criteria)a 2,262 1.00 10,229 0.41 0.39–0.44 <.001 2,186 0.24 0.22–0.25 <.001
Self-reports
 Poor/fair self-perceived health 6,220 1.00 31,331 0.34 0.33–0.35 <.001 6,010 0.16 0.15–0.17 <.001
 Chronic pain lasting >3 mo 6,566 1.00 54,991 0.68 0.65–0.70 <.001 17,907 0.52 0.50–0.54 <.001
Measures
 Low FEV1 (lowest 20%; sex specific) 3,340 1.00 21,542 0.53 0.51–0.55 <.001 5,298 0.33 0.31–0.35 <.001
 Low grip strength (lowest 20%; sex specific) 2,335 1.00 17,126 0.72 0.69–0.76 <.001 5,969 0.71 0.67–0.75 <.001
Note: CI = confidence interval; CV = cardiovascular; FEV1 = forced expiratory volume in 1 second; OR = odds ratio. Adjusted for age, sex, socioeconomic status 
(education and Townsend deprivation index) and ethnicity.
aFrailty: ≥2 weight loss, exhaustion, slow walking pace, low grip strength (excludes physical activity because this is included in the CV risk score).
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versus high CRS (Table  3). Those with low CRS were less likely 
to report “poor or fair” health (OR = 0.16; CI = 0.15–0.17), less 
chronic pain (OR = 0.52, CI = 0.50–0.54), and were less likely to be 
in the lowest sex-specific quintile of forced expiratory volume in 1 
second (OR = 0.33, CI = 0.31–0.35). For all these outcomes, there 
were intermediate risk reductions in the intermediate CRS group.
Incident Outcomes During Follow-up (UKB 
and CPRD)
As expected, incidence of all-cause mortality, coronary artery dis-
ease, and stroke was substantially lower with low and intermedi-
ate risks (vs. high CRS), with a dose–response trend (Figure 1 and 
Supplementary Table 1). Low CRS was associated with lower inci-
dence of heart failure (CPRD: sub-HR = 0.20, CI = 0.14–0.28; UKB: 
sub-HR = 0.27, CI = 0.23–0.31) during follow-up. A more modest 
trend was observed for incident cancer (excluding non-melanoma 
skin cancer: CPRD: sub-HR  =  0.88, CI  =  0.80–0.97; UKB: sub-
HR = 0.76, CI = 0.70–0.81). Hazards of respiratory conditions were 
markedly lower in the low CRS group, including chronic obstructive 
pulmonary disease and asthma, in both CPRD and UKB (Table 4 
and Figure  1). Incident depression was less common in the low 
CRS group in both cohorts. For incident hospital diagnosed demen-
tia, a significant reduction was observed in UKB for the low CRS 
group, with a similar but nonsignificant trend in CPRD (UKB: sub-
HR = 0.67, CI = 0.50–0.89; CPRD: sub-HR = 0.79, CI = 0.56–1.12).
CPRD (but not UKB) allowed estimation of the incidence of 
clinical geriatric syndromes by CRS group (Table 4 and Figure 1). 
Pressure sores and ulcers (sub-HR = 0.32, CI = 0.23–0.44), incon-
tinence (sub-HR  =  0.75, CI  =  0.63–0.91), falls (sub-HR  =  0.82, 
CI  =  0.73–0.91), and hospitalization with fragility fractures (sub-
HR = 0.78, CI = 0.65–0.93) were all less common in those with low 
CRS compared with high CRS. Those with low CRS also had lower 
incidence of osteoarthritis (CPRD: sub-HR = 0.72, CI = 0.65–0.80). 
Estimates again showed dose–response relationships, with interme-
diate risk reductions comparing intermediate to high CRS.
Low (sub-HR  =  0.15, CI  =  0.10–0.21) and intermediate CRS 
(sub-HR = 0.38, CI = 0.37–0.4) were associated with substantially 
lower incidence of frailty (Figure 2) compared with the high CRS 
group. Intermediate CRS were associated with intermediate inci-
dence of frailty, with a dose–response relationship.
Additional Sensitivity Analyses
Stratified CPRD analyses comparing individuals with complete 
data (n = 71,082) and with at least one missing value (n = 168,509) 
showed similar proportions in the low CRS group (2.3% vs. 2.4%; 
Supplementary Table 2). Estimates for the association between the 
CRS and all-cause mortality were comparable between both groups, 
although the protective effect of low risk was attenuated for those 
with missing data (no missing data OR = 0.35, CI = 0.25–0.51 vs. 
missing date OR = 0.41, CI = 0.34–0.48; Supplementary Table 3).
An analysis for all-cause mortality with adjustments lim-
ited to age and sex, variables available in both cohorts, produced 
similar estimates to the fully adjusted models (UKB: HR  =  0.43, 
95% CI  =  0.40–0.47; CPRD: HR  =  0.38, 95% CI  =  0.32–0.44; 
Supplementary Table  4). This suggests the different adjustment 
between cohorts is not driving the results reported. In addition, an 
analysis excluding participants with a previous history of cardiovas-
cular events (coronary heart disease, stroke, or heart failure) from 
the analysis—46,657 (19.5%) in CPRD compared with 20,142 
(11.1%) in UK Biobank—did not significantly change estimates 
(Supplementary Tables 5 and 6).
Discussion
We describe the first analysis of associations between having near 
ideal cardiovascular risk factor profiles and clinical geriatric out-
comes not directly related to CVD. We used two large-scale cohorts 
selecting individuals aged 60–69 years old at baseline and both fol-
lowed for up to 10 years. Our findings show that older adults with 
these low CVD risk profiles experience substantially better outcomes 
in a wide range of health domains typically associated with aging. In 
particular, the low CVD risk profile was associated with markedly 
lower risks of frailty on both the Fried and Rockwood approaches to 
defining frailty. Estimates for all conditions were remarkably similar 
in the two cohorts despite one being population representative and 
the other composed of healthier volunteers. There were also differ-
ences in risk factor ascertainment in the two datasets, but the simi-
larity of estimates obtained suggests that the results are robust.
Overall, our results suggest that taking the necessary steps to 
achieve lower CVD risk could not only prevent CVD outcomes but 
also improve health in later life and help to avoid or delay the delete-
rious consequences on aging. Although the relevance of our findings 
for maximizing the chance of healthy aging is evident, our findings 
also suggest that CVD risk factors also act as risk factors for many 
of the chronic conditions that show increased prevalence with aging 
and are also frequent causes of disability and frailty.
Comparison to Previous Studies
Our results are consistent with studies where cardiovascular risk 
factor scores were applied to younger cohorts (20). The preva-
lence of low cardiovascular risks in CPRD, which can be con-
sidered a representative sample of the general population, was 
comparable to a community-based middle-aged America adults 
Figure  1. Hazard ratios (95% confidence intervals) for mortality and 
subhazard ratios (competing risk models) for incident conditions for 
individuals in the low cardiovascular disease risk score (CRS) (high CRS as 
reference), during ≤10 years of follow-up. Clinical Practice Research Datalink 
(CPRD) (n = 239,591): Adjusted for age, sex, index of multiple deprivation, 
and year of admission into the study. UK Biobank (n  =  181,820): Adjusted 
for age, sex, ethnicity, education, and socioeconomic deprivation index 
(Townsend deprivation index). Participants with prevalent disease at baseline 
were excluded. Cancer excludes non-melanoma skin cancer.
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(mean age of 59 years), which found <1% having ideal cardio-
vascular risks (21,22). Low CVD risks are unsurprisingly much 
more common in UKB, which recruited volunteers willing to 
attend examination centers, with a resulting healthier cohort at 
baseline (11).
We confirmed markedly lower incidence of coronary heart dis-
ease and stroke and a more modest reduction in cancer incidence 
with near ideal CVD risks, as reported previously (23–25), and 
hence, this validates our measure of the CRS. Our CRS and heart 
failure associations are similar to a study on 13,462 adults aged 
45–64  years, which also reported greater preservation of cardiac 
structure and function over 25 years of follow-up (26).
We also observed strong associations between low cardiovas-
cular risk and noncardiovascular outcomes. The protective effect of 
near ideal cardiovascular risk was also present for incident hospital 
diagnosed dementia: Analysis in UKB yielded a significant overall 
dementia incidence reduction of 33%, although the point estimate 
did not reach significance in CPRD. This result is consistent with 
two studies of Life’s Simple 7 cardiovascular risk score (with smaller 
populations: 3,547 (24) and 6,505 individuals (27)), analyzing in-
cident dementia in populations including but not limited to age 
60–69 years, which identified nonsignificant reductions in the risk of 
incident dementia (of 28% (24) and 20% (27)). We observed mark-
edly lower risks of frailty, using both the Fried and Rockwood defi-
nitions, in low CVD risk individuals. Previous research has shown 
cross-sectional associations between frailty and cardiovascular risk 
factors including high-density lipoprotein cholesterol and hyper-
tension (28), suggesting common inflammatory pathways may be 
involved (29). We also confirmed a markedly lower incidence of de-
pression in low CVD risk individuals (30), as well as a decreased 
risk of chronic pain and late-onset asthma in individuals with lower 
cardiovascular risk (31–33). The later effects may be driven by lower 
overall weight in these individuals with lower CRS (31–33).
Strengths and Limitations
Strengths of this study include the large sample sizes and the popu-
lation representativeness of CPRD, which is inclusive of older adults 
living in nursing homes and with cognitive impairment (7). We also 
found very similar risk reductions in the two different cohorts, sug-
gesting that estimates are robust.
In UKB, measured cholesterol and glucose levels were not avail-
able, so we used proxy markers such as diagnoses of hypercholester-
olemia or diabetes, or related treatment receipt to classify risk factor 
Table 4. Subhazard Ratios for Incident Conditions by Cardiovascular Risk Score in Adults Aged 60–69 Years From CPRD (n = 239,591) and 
UK Biobank (n = 181,820) During ≤10-Year Follow-up
High CV Risk 
(0–5)
Intermediate  
CV Risk (6–9)
Low  
CV Risk (10–12)
Cases Ref. Cases HR 95% CI p Value Cases HR 95% CI p Value
CPRD
 Frailty (RFI) 4,532 1.00 2,879 0.38 0.37–0.4 <.001 29 0.15 0.1–0.21 <.001
 COPDa 5,411 1.00 5,372 0.57 0.55–0.6 <.001 58 0.20 0.15–0.26 <.001
 Asthmaa 2,835 1.00 3,500 0.73 0.69–0.77 <.001 62 0.42 0.33–0.54 <.001
 Depressiona 3,984 1.00 5,007 0.71 0.68–0.74 <.001 132 0.58 0.49–0.69 <.001
 Dementiaa 995 1.00 1,633 1.00 0.92–1.08 .961 33 0.79 0.56–1.12 .178
 Osteoarthritisa 9,030 1.00 13,965 0.86 0.84–0.88 <.001 381 0.72 0.65–0.80 .007
 Pressure sores and ulcersa 2,485 1.00 2,211 0.53 0.50–0.57 <.001 37 0.32 0.23–0.44 <.001
 Incontinencea 3,008 1.00 4,305 0.85 0.81–0.89 <.001 120 0.75 0.63–0.91 .003
 Fallsa 7,753 1.00 11,300 0.87 0.84–0.89 <.001 312 0.82 0.73–0.91 <.001
 Hospitalization with fragility fracturesa 2,968 1.00 4,444 0.88 0.84–0.92 <.001 120 0.78 0.65–0.93 .007
UK Biobank
 COPDa 537 1.00 2,251 0.47 0.43–0.52 <.001 399 0.26 0.23–0.29 <.001
 Asthmaa 184 1.00 1,403 0.75 0.64–0.88 <.001 350 0.49 0.41–0.59 <.001
 Depressiona 224 1.00 1,418 0.62 0.54–0.71 <.001 380 0.43 0.37–0.51 <.001
 Dementiaa 71 1.00 457 0.70 0.55–0.90 .005 142 0.67 0.50–0.89 .006
Note: CI = confidence interval; COPD = chronic obstructive pulmonary disease; CPRD = Clinical Practice Research Datalink; CV = cardiovascular; HR = hazard 
ratio; RFI = Rockwood's frailty index. CPRD: adjusted for age, sex, index of multiple deprivation and year of admission into the study. UK Biobank: adjusted for 
age, sex, ethnicity, education, socioeconomic deprivation index (Townsend deprivation index).
aCompeting risk models (subhazard ratios). Excludes participants with prevalent disease at baseline.
Figure  2. Incidence (%) of moderate to severe frailty (>0.24 on Rockwood 
multi-morbidity count criteria) in 60–69  year olds from Clinical Practice 
Research Datalink, classified as fit or mild (n = 238,501) during ≤10 years of 
follow-up. Frailty measured using Rockwood’s frailty index, with individuals 
classified as moderate or severe frailty (Rockwood’s frailty index > 0.24) at 
study entry date excluded from the analysis.
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status. Given that the treatments have been shown in randomized 
trials to be effective at CVD risk reduction, our classification of 
these risks as high is somewhat conservative. In CPRD, nonrecord-
ing of risk factors by general practitioners is not at random (rather 
likely reflecting the absence of clinical symptoms, signs, and low 
clinical suspicion), making multiple imputation of missing data in-
appropriate. We took the prudent approach of assigning those with 
missing values to the low CRS group and showed comparable asso-
ciations between the CRS and all-cause mortality in those with and 
without missing data. Both of these approaches are conservative, 
that is, in UKB perhaps including some individuals on treatment as 
high risk when their true risk level was reduced and in CPRD pos-
sibly including some individuals with no data on risks recorded as 
not having low risks when they actually had CVD risk factors: The 
combined effects of these conservative approaches may have led to 
underestimation of true effect sizes.
In addition, in CPRD, for cholesterol and glucose measurements, 
a long lead-in period of up to 8.5 years were defined, with the sup-
port from clinicians, on the basis of the available data for building a 
cohort. This presents the possibility that people with a normal blood 
test value might develop the condition of interest (eg, high choles-
terol and fasting glucose) and thus be misclassified. However, this 
misclassification will bias results toward the null and is unlikely to 
have influenced the direction of our results. In the CPRD primary 
care records, people with CVD risk factors may have been seen by 
primary care during follow-up more often, with better ascertain-
ment of outcomes. However, our ascertainment of outcomes in both 
studies included hospital admission records and death certificates, 
so at least for the more severe health events, ascertainment of out-
comes was likely unbiased. Also, we highlight that the inclusion of 
hypertension and diabetes as components of the Rockwood frailty 
index contribute to a higher frailty score for those with higher CRS. 
However, as this influence is constant for frailty estimates over time 
(at index date as well as throughout the follow-up period), expecta-
tion is that the effect is minimized for the analysis of frailty progres-
sion over time.
Some of the risk factor measures may reflect elements of sub-
clinical pathology, perhaps from early life exposures that may not 
be amenable to intervention. However, there are many clinical trials 
of, for example, blood pressure and cholesterol reduction in middle 
age or later life that have reported large reductions in CVD risk and 
mortality (34,35), suggesting that risks even in midlife and later life 
are susceptible to change. Clearly, only randomized trials of compre-
hensive risk reduction for improving aging outcomes could provide 
definitive data, and such studies should be given high priority.
Future work should seek to study this question with a more com-
plete set of measured risk factors. Future analyses could also separate 
the CRS into behavioral risk factors (eg, smoking and physical ac-
tivity) and more proximal cardiovascular risk factors to tease out 
the effects of overlapping risk factors. Studies of inherited genetic 
risks could help provide unconfounded estimates for lifelong ex-
posure to many of the studied risk factors. Interestingly, our recent 
genome-wide association study (GWAS) of parental longevity (36) 
in UK Biobank found strong associations with lower genetic risks 
scores for several cardiovascular traits, including CVD, adverse lipid 
levels, and blood pressure. Our GWAS also identified a variant linked 
to smoking was associated with father’s survival. This suggests that 
genetic propensity to several of the cardiovascular risk factors used 
here in the CRS is associated with mortality and hence morbidity and 
that the CVD risk factor associations reported are likely to be causal.
Conclusions
Adults aged 60–69 years with low cardiovascular risks not only have 
lower incidence of CVD events but they are also less likely to develop 
many clinical outcomes that typically develop in older patients. The 
dose–response associations seen with lower CVD risks may be causal, 
given the genetic evidence and the positive effects of treatment seen in 
randomized trials, even at advanced ages. Unfortunately, only a small 
proportion of the older population have near ideal CVD risk factor 
profiles. Optimizing CVD risk factors may substantially reduce the 
burden of morbidity in later life and improve aging trajectories.
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